Fig. 3

Analysis schema to identify prognostic clinical, molecular and immune prognostic factors in MBM patients. First, univariate analysis of indicated clinical factors, molecular features, and immune features were performed separately. Features with p < 0.1 on univariate analysis were utilized in multivariate analysis to identify independent predictors of OS in MBM patients